Found: 17
Select item for more details and to access through your institution.
Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1093, doi. 10.1111/dom.12757
- By:
- Publication type:
- Article
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1089, doi. 10.1111/dom.12754
- By:
- Publication type:
- Article
Islet Autoimmunity Identifies a Unique Pattern of Impaired Pancreatic Beta-Cell Function, Markedly Reduced Pancreatic Beta Cell Mass and Insulin Resistance in Clinically Diagnosed Type 2 Diabetes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106537
- By:
- Publication type:
- Article
Short-term exercise improves beta-cell function and insulin resistance in older people with impaired glucose tolerance.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Impaired β-Cell Function in Human Aging: Response to Nicotinic Acid-Induced Insulin Resistance.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 9, p. 3303, doi. 10.1210/jc.2006-0913
- By:
- Publication type:
- Article
Limitation of the Homeostasis Model Assessment to Predict Insulin Resistance and β-Cell Dysfunction in Older People.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 2, p. 629, doi. 10.1210/jc.2005-1803
- By:
- Publication type:
- Article
The Role of Hepatic Glucose Production and Impaired Insulin Secretion in Age-Related Impaired Glucose Tolerance.
- Published in:
- Diabetes, 2007, v. 56, p. A383
- By:
- Publication type:
- Article
The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The GLP-1 Derivative NN2211 Restores β-Cell Sensitivity to Glucose in Type 2 Diabetic Patients After a Single Dose.
- Published in:
- Diabetes, 2003, v. 52, n. 7, p. 1786, doi. 10.2337/diabetes.52.7.1786
- By:
- Publication type:
- Article
Assessing Time in Range with Postprandial Glucose-Focused Titration of Ultra Rapid Lispro (URLi) in People with Type 1 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 11, p. 1933, doi. 10.1007/s13300-023-01476-4
- By:
- Publication type:
- Article
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 5, p. 883, doi. 10.1007/s13300-023-01400-w
- By:
- Publication type:
- Article
Efficacy and Safety of Ultra-Rapid Lispro in Younger and Older Patients with Type 2 Diabetes: Randomized Double-Blind PRONTO-T2D Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 8, p. 1547, doi. 10.1007/s13300-022-01290-4
- By:
- Publication type:
- Article
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.
- Published in:
- 2016
- By:
- Publication type:
- journal article
107-LB: Relative Contribution of Fasting Plasma and Postprandial Glucose to HbA1c and TIR in People with T1D on Basal-Bolus Insulin Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-107-LB
- By:
- Publication type:
- Article
1046-P: Effect of Age on HbA1c, Postprandial Glucose (PPG) Control, and Hypoglycemia in Patients with T2D Treated with Ultra-Rapid Lispro (URLi) or Humalog: PRONTO-T2D.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1046-P
- By:
- Publication type:
- Article
145-OR: Ultra Rapid Lispro (URLi) Improves Postprandial Glucose (PPG) Control vs. Humalog (Lispro) in Patients with Type 2 Diabetes (T2D): PRONTO-T2D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-145-OR
- By:
- Publication type:
- Article